210 related articles for article (PubMed ID: 25511798)
1. Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
Wang Y; Fan X; Zhang W; Zhang C; Wang J; Jiang T; Wang L
J Neurooncol; 2015 Feb; 121(3):609-16. PubMed ID: 25511798
[TBL] [Abstract][Full Text] [Related]
2. Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas.
Fan X; Wang YY; Zhang CB; You G; Li MY; Wang L; Jiang T
J Cancer Res Clin Oncol; 2015 Apr; 141(4):729-34. PubMed ID: 25304616
[TBL] [Abstract][Full Text] [Related]
3. FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
Wang Y; Tang K; Zhao J; Liu L; Feng J
Seizure; 2017 Nov; 52():41-45. PubMed ID: 28963932
[TBL] [Abstract][Full Text] [Related]
4. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
5. Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
Li L; Fang S; Li G; Zhang K; Huang R; Wang Y; Zhang C; Li Y; Zhang W; Zhang Z; Jin Q; Zhou D; Fan X; Jiang T
J Neurosurg; 2022 Jan; 136(1):67-75. PubMed ID: 34243149
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN
Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870
[TBL] [Abstract][Full Text] [Related]
7. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
8. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
10. Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide.
Koekkoek JA; Dirven L; Heimans JJ; Postma TJ; Vos MJ; Reijneveld JC; Taphoorn MJ
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):366-73. PubMed ID: 25055819
[TBL] [Abstract][Full Text] [Related]
11. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance proteins expression in glioma patients with epilepsy.
Calatozzolo C; Pollo B; Botturi A; Dinapoli L; Carosi M; Salmaggi A; Maschio M
J Neurooncol; 2012 Oct; 110(1):129-35. PubMed ID: 22832898
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers related with seizure risk in glioma patients: A systematic review.
Zhou XW; Wang X; Yang Y; Luo JW; Dong H; Liu YH; Mao Q
Clin Neurol Neurosurg; 2016 Dec; 151():113-119. PubMed ID: 27821299
[TBL] [Abstract][Full Text] [Related]
15. [Factors associated with the surgical efficacy and prognosis of seizures in patients with low-grade glioma].
Fang F; Lin YX; Kang DZ; Wang F; Huang XF; Yu LH; Lin ZY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1031-4. PubMed ID: 27055796
[TBL] [Abstract][Full Text] [Related]
16. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
Ius T; Ciani Y; Ruaro ME; Isola M; Sorrentino M; Bulfoni M; Candotti V; Correcig C; Bourkoula E; Manini I; Pegolo E; Mangoni D; Marzinotto S; Radovic S; Toffoletto B; Caponnetto F; Zanello A; Mariuzzi L; Di Loreto C; Beltrami AP; Piazza S; Skrap M; Cesselli D
Neuro Oncol; 2018 May; 20(6):776-787. PubMed ID: 29228370
[TBL] [Abstract][Full Text] [Related]
17. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping.
Wang Y; Qian T; You G; Peng X; Chen C; You Y; Yao K; Wu C; Ma J; Sha Z; Wang S; Jiang T
Neuro Oncol; 2015 Feb; 17(2):282-8. PubMed ID: 25031032
[TBL] [Abstract][Full Text] [Related]
18. Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma.
Zhang H; Zhang L; Tang Y; Wang C; Chen Y; Shu J; Zhang K
Biomed Pharmacother; 2019 Oct; 118():109215. PubMed ID: 31545245
[TBL] [Abstract][Full Text] [Related]
19. Epileptic seizures and survival in early disease of grade 2 gliomas.
Danfors T; Ribom D; Berntsson SG; Smits A
Eur J Neurol; 2009 Jul; 16(7):823-31. PubMed ID: 19473357
[TBL] [Abstract][Full Text] [Related]
20. Epilepsy surgery related to pediatric brain tumors: Miami Children's Hospital experience.
Fallah A; Weil AG; Sur S; Miller I; Jayakar P; Morrison G; Bhatia S; Ragheb J
J Neurosurg Pediatr; 2015 Dec; 16(6):675-80. PubMed ID: 26339959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
